[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$jbio
$JBIO Jade Biosciences presents new preclinical data for JADE101 and JADE201 at ASN Kidney Week 2025, showing a favorable safety profile and biomarker responses. The company also announced a $XXX million private placement to fund autoimmune disease therapies.
About $jbio
$JBIO is a decentralized digital currency and its associated ecosystem.
Insights
- $jbio creators is up XXXX% from the previous month.
- $jbio mentions is up XXXXX% from the previous month.
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX +26%
X Months: XXXXXXX +1,028%
X Year: XXXXXXX +6,924%
1-Year High: XXXXXX on 2025-06-09
1-Year Low: X on 2025-09-08
Engagements by network (24h): X: XXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX +12%
X Month: XX +96%
X Months: XXXXX +4,183%
X Year: XXXXX +57,425%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2024-12-24
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $jbio in the last XX hours which is up XXX% from X in the previous XX hours
Daily Average: XX
X Week: XX +23%
X Month: XX +44%
X Months: XXXXX +5,167%
X Year: XXXXX +58,400%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2024-12-24
The most influential creators that mention $jbio in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Quantumup1 | X | XXXXX | X | XXX |
| @seedytx19 | X | XXXXX | X | XXX |
| @zohmbastic | X | XXXXX | X | XX |
| @TopStockAlerts1 | X | XXXXXXX | X | XX |
| @TheOptionsBull2 | X | XXX | X | XX |
| @CoachNickMoney | X | XXXXXX | X | XX |
| @CrweWorld | X | XXXXX | X | X |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% +67%
X Months: XXX% +50%
1-Year High: XXX% on 2025-04-29
1-Year Low: XX% on 2025-08-07
Most Supportive Themes:
- Increased Mentions and Engagements: (75%) The topic is seeing a significant increase in social media mentions and engagements, indicating growing interest and discussion within the community.
- Creator Activity: (25%) There is a notable increase in the number of active creators discussing the topic, suggesting a healthy and expanding base of content producers.
Most Critical Themes:
Top $jbio Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Pre Market Top Gainers PT2 $MSS $VIXI $WAI $JBIO $GNSS"
X Link @TopStockAlerts1 2025-11-28T13:55Z 122.3K followers, XXX engagements
"$VERA picked up shares and the Dec $XX calls"
X Link @MinervaCap 2025-11-26T15:35Z 1915 followers, XXX engagements
"Cantor reit'd $VERA OW-$100/saidWe continue to view VERA shares as undervalued ($1.8B mkt cap with $497M cash as of Sep 30) given the competitive profile in lgAN a multi-$B market that can easily accommodate multiple disease-modifying B cell modulators. $OTSKY $JBIO ALNY ABBV VRTX NVS IONS Cantor additionally said: This view is in line with that of multiple investors we spoke to at ASN who believe IgAN is a $10B market for B-cell modulators. Our math suggests IgAN patients with proteinuria XXX g/day (76% according to literature (here)) represent 85K-151K US patients. Assuming annualized"
X Link @Quantumup1 2025-11-26T12:21Z 3921 followers, 10.6K engagements
"Clear Street🏁 $JBIO Buy/$25 $OTSKY $TVTX NVS VRTX IONS AZN CALT Clear Street saidWe initiate JBIO coverage with a Buy rating and a $XX PT underscoring our firm conviction in JADE101a potential best-in-class anti-APRIL mAb poised to reshape the IgAN therapeutic landscape. Jade's market entry is impeccably timed (vs. its precedents) as new treatment (KDIGO) guidelines now advocate the first-line use of agents like JADE101 and expand patient eligibility. Distinguished by superior dosing flexibility (Q8W+) and the convenience afforded by YTE modifications JADE101 decisively outshines"
X Link @Quantumup1 2025-11-25T11:52Z 3927 followers, 1253 engagements